Whether in a senior citizen with diabetes or in a young patient who suffered a traumatic injury, rock-hard cataracts pose a challenge to remove and need extra postoperative steps to ensure proper recovery.Young or old, good vision or poor vision, it ca…
Month: October 2018
Surgeons can help themselves by helping their management staff thrive
“Investing in management means building communication systems, business processes, feedback, and routines that let you scale the business and team as efficiently as possible.” – Fred Wilson“A good teacher must be able to put himself in the place of tho…
Rock-hard cataracts require more planning, intraoperative skill
The cataract with an extremely dense and hard brunescent nucleus, or so-called “catarock,” is challenging surgery for any ophthalmic surgeon. There is often also a reduced endothelial cell count, a poorly dilating pupil, and weak or partially absent zo…
Premium surgeons should help patients navigate vicious maze of care access
Premium surgeons face challenges regarding patient care access daily, from access to certain eye drop pharmaceuticals to a growing population of aging patients living longer and the cataract pool ever-enlarging to the health insurance industry making d…
Letter to the Editor
To the editor:I am writing in response to the June 25, 2018, commentary regarding the evolution of care models for diabetic macular edema. I think the conclusions reached in the paper do not accurately reflect physician experience with Iluvien implants…
Is it your preference to use femtosecond laser-assisted cataract surgery for dense cataracts?
Click here to view the Cover Story for this Point/Counter.Some surgeons question the need for and value of FLACS for the management of routine cataract cases. In my experience, this technology has demonstrated benefits in certain conditions such as tho…
Growing Hope: Building a teaching hospital in Africa
In the face of harsh realities in sub-Saharan Africa, John Cropsey, MD, and a cadre of colleagues are partnering with Hope Africa University to grow a teaching hospital.Kibuye Hope Hospital (KHH) is 6,000 feet high in the mountains of Burundi and a 2.5…
Flanged intrascleral IOL fixation with double-needle technique
The intrascleral IOL fixation technique was reported by Scharioth and Agarwal as a sutureless technique for IOL fixation. This technique has become a popular procedure because it has some advantages over conventional trans-scleral suturing of the IOL. …
Elimination of corneal blindness poses large-scale challenge
I have had the privilege of being a member of the board of directors of SightLife for just more than a year now, and during that time, I have been a witness to SightLife’s tenacious commitment to eradicating corneal blindness across the globe. When I e…
RightEye Secures FDA 510(k) Clearance for Eye-Tracking Platform
A couple months ago, Medgadget reviewed RightEye’s EyeQ vision tests and training tools in addition to speaking with Co-Founder and CSO Dr. Melissa Hunfalvay. As a platform to help providers assess eyesight, brain and reading disorders, and performance issues, RightEye captures much of its data using state-of-the-art eye tracking technology and realizes engagement through gamification. Today, […]
US Macular Edema Market and Competitive Landscape 2014-2023 – Pipeline, Epidemiology, Market Valuations, Product Sales, Market Forecast, Product Forecasts, and Market Shares – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “US Macular Edema Market and Competitive Landscape – 2018” report has been added to ResearchAndMarkets.com’s offering. US Macular Edema Market and Competitive Landscape – 2018 provides comprehensive insights into Macular Ed…
Drugs could one day treat nearsightedness, reveals gene study
The molecular pathways involved in the development of near- and farsightedness are different, according to an animal study of gene changes in the retina.
VIDEO: Full scope of facial aesthetics treatments changing practice
NEW YORK — From Facial Aesthetics New York 2018, Steven L. Davis, MD, discusses how the wide range of treatment options available today, from surgical to noninvasive procedures, can give surgeons a great variety of tools for treating patients.
Kedalion Therapeutics to Present at 2018 BIO Investor Forum
MENLO PARK, Calif.–(BUSINESS WIRE)–Kedalion Therapeutics to Present at BIO Investor Forum
Turn-Key Health Hosts AHIP Panel, October 16, 2018: Highlights CMS Expansion of Med Advantage Supplemental Benefits Coverage
PHILADELPHIA–(BUSINESS WIRE)–Turn-Key Health Hosts AHIP Panel, October 16, 2018: Highlights CMS Expansion of Med Advantage Supplemental Benefits Coverage
Steps clinicians can take toward proper compensation
Several times throughout European history, the law set limits on what medical services patients could be billed for and some clinicians could not bill for services at all or sue to collect fees, lawyers Mark A. Hall and Carl E. Schneider wrote in the J…
Ocugen begins phase 3 trial of OCU310 for dry eye
Ocugen has initiated a phase 3 clinical trial of its dry eye disease treatment OCU310, the company announced in a press release.OCU310 (brimonidine tartrate 0.2%), an investigational twice-daily, steroid-free, preservative- free eye drop, is formulated…
Resumen: Keen Eye e Iris Pharma se unen para ofrecer inteligencia artificial a estudios oftalmológicos
PARÍS–(BUSINESS WIRE)–Keen Eye, una compañía tecnológica francesa especializada en análisis de imágenes para el sector de las ciencias de la vida, ha anunciado hoy un acuerdo de asociación estratégica con Iris Pharma, una organización de investigació…
Samenvatting: Keen Eye en Iris Pharma werken samen om kunstmatige intelligentie in te voeren bij oftalmologische studies
PARIJS–(BUSINESS WIRE)–Keen Eye, een Frans technologiebedrijf gespecialiseerd in beeldanalyse voor de biowetenschappelijke industrie, kondigde vandaag een strategische partnerschapsovereenkomst aan met Iris Pharma, een wereldwijd toonaangevende contr…
Riassunto: Keen Eye e Iris Pharma collaborano per portare l’intelligenza artificiale negli studi in campo oculistico
PARIGI–(BUSINESS WIRE)–Keen Eye, società tecnologica francese specializzata nell’analisi delle immagini per l’industria nel settore delle scienze biologiche, ha oggi annunciato un accordo di collaborazione strategica con Iris Pharma, organizzazione d…